AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29533264 — intervention group
Group type: COMPARATOR
Intervention: Major Adverse Postoperative Events (MAPEs) with troponin elevation but without MI
Number of subjects: 6992
Study 29533264 — intervention group
Group type: COMPARATOR
Intervention: Troponin elevation (all types)
Number of subjects: 6992
Study 26493601 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based cognitive-behavioral therapy for chronic pain
Number of subjects: 330
Study 24898857 — intervention group
Group type: COMPARATOR
Intervention: BufferGel
Number of subjects: 3099
Study 24898857 — intervention group
Group type: COMPARATOR
Intervention: PRO 2000
Number of subjects: 3099
Study 22238412 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS(R) before PT
Number of subjects: 30
Study 22238412 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS(R) after PT
Number of subjects: 30
Study 22238412 — intervention group
Group type: COMPARATOR
Intervention: rTMS(S)
Number of subjects: 30
Study 22238412 — intervention group
Group type: COMPARATOR
Intervention: Control (Sham rTMS)
Number of subjects: 30
Study 18503493 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 645
Study 18503493 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived barriers to physical activity (e.g., poor health, fear, negative experiences, lack of knowledge)
Number of subjects: 645
Study 18503493 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking time over 10 m (adjustment)
Number of subjects: 645
Study 18503493 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise promotion programs
Number of subjects: 645
Study 17768009 — intervention group
Group type: EXPERIMENTAL
Intervention: Work style intervention (WS)
Number of subjects: 466
Study 17768009 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (WSPA)
Number of subjects: 466
Study 17768009 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 466
Study 14720530 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic low-frequency electrical stimulation (CLFS) of thigh muscles
Number of subjects: 32
Study 14720530 — intervention group
Group type: COMPARATOR
Intervention: Control group (no muscle contractions, current input up to sensory threshold)
Number of subjects: 32
Study 12103293 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster B flamboyant group (antisocial, histrionic)
Number of subjects: 202
Study 12103293 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster A odd, eccentric group (schizoid, schizotypal, paranoid)
Number of subjects: 202
Study 12103293 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster C anxious, fearful group (obsessional, avoidant)
Number of subjects: 202
Study 12103293 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline and 12-year personality clusters
Number of subjects: 202
Study 9689428 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 4 x 150 mg or tetracycline 4 x 500 mg or metronidazole 3 x 250 mg for 2 weeks
Number of subjects: 201
Study 9689428 — intervention group
Group type: COMPARATOR
Intervention: Placebo + tetracycline and metronidazole as in group A for 2 weeks
Number of subjects: 201
Study 9689428 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine combined with tetracycline and metronidazole
Number of subjects: 201
Study 9689428 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline and metronidazole alone
Number of subjects: 201
Study 8206564 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 202
Study 8206564 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 202
Study 8206564 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide with oral potassium
Number of subjects: 202
Study 8206564 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide with oral potassium and magnesium
Number of subjects: 202
Study 8206564 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide and triamterene
Number of subjects: 202
Study 8206564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 2543309 — intervention group
Group type: EXPERIMENTAL
Intervention: Syo‐saiko‐to (7.5 g/day)
Number of subjects: 260
Study 2543309 — intervention group
Group type: COMPARATOR
Intervention: Conventional medicine (control group)
Number of subjects: 260
Study 30738342 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectation of teaching with unlimited motor preparation
Number of subjects: 0
Study 30738342 — intervention group
Group type: COMPARATOR
Intervention: Expectation of teaching with limited motor preparation
Number of subjects: 0
Study 30738342 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectation of being tested with unlimited motor preparation
Number of subjects: 0
Study 30738342 — intervention group
Group type: COMPARATOR
Intervention: Expectation of being tested with limited motor preparation
Number of subjects: 0
Study 30738342 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative analysis from two prior experiments
Number of subjects: 0
Study 28910291 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive expectation induction with verbal suggestion (experimental group)
Number of subjects: 0
Study 28910291 — intervention group
Group type: COMPARATOR
Intervention: Negative expectation induction (control group 1)
Number of subjects: 0
Study 28910291 — intervention group
Group type: COMPARATOR
Intervention: Extinction procedure (control group 2)
Number of subjects: 0
Study 28910291 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine application test (after intervention)
Number of subjects: 0
Study 26022817 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg, n = 519
Number of subjects: 1030
Study 26022817 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n = 511
Number of subjects: 1030
Study 23651076 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sucrose (S)
Number of subjects: 25
Study 23651076 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated tucking (FT)
Number of subjects: 25
Study 23651076 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oral sucrose and facilitated tucking (SFT)
Number of subjects: 25
Study 23651076 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study 22127194 — intervention group
Group type: EXPERIMENTAL
Intervention: nortriptyline
Number of subjects: 811
Study 22127194 — intervention group
Group type: EXPERIMENTAL
Intervention: escitalopram
Number of subjects: 811
Study 19162420 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 933
Study 19162420 — intervention group
Group type: COMPARATOR
Intervention: Non-olanzapine antipsychotic
Number of subjects: 933
Study 19162420 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 933
Study 17682120 — intervention group
Group type: EXPERIMENTAL
Intervention: Cod protein diet
Number of subjects: 19
Study 17682120 — intervention group
Group type: COMPARATOR
Intervention: BPVEM diet (lean beef, pork, veal, eggs, milk, and milk products)
Number of subjects: 19
Study 15383197 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg levofloxacin
Number of subjects: 528
Study 15383197 — intervention group
Group type: COMPARATOR
Intervention: 500 mg levofloxacin
Number of subjects: 528
Study 15231903 — intervention group
Group type: EXPERIMENTAL
Intervention: Chelation therapy with succimer
Number of subjects: 780
Study 15231903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 780
Study 10931120 — intervention group
Group type: EXPERIMENTAL
Intervention: Atopic rhinitic children
Number of subjects: 375
Study 10931120 — intervention group
Group type: EXPERIMENTAL
Intervention: Atopic control children
Number of subjects: 375
Study 10931120 — intervention group
Group type: COMPARATOR
Intervention: Nonatopic rhinitic subjects
Number of subjects: 375
Study 10931120 — intervention group
Group type: COMPARATOR
Intervention: Nonatopic control subjects
Number of subjects: 375
Study 10931120 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with positive skin response to CRM
Number of subjects: 375
Study 10931120 — intervention group
Group type: COMPARATOR
Intervention: Children without sensitization to CRM
Number of subjects: 375
Study 9485981 — intervention group
Group type: EXPERIMENTAL
Intervention: atracurium
Number of subjects: 50
Study 9485981 — intervention group
Group type: COMPARATOR
Intervention: vecuronium
Number of subjects: 50
Study 8150546 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (2.5 to 10 mg) once daily
Number of subjects: 139
Study 8150546 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) (25 to 100 mg) daily
Number of subjects: 139
Study 8150546 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine-atenolol combination therapy
Number of subjects: 139
Study 8150546 — intervention group
Group type: COMPARATOR
Intervention: HCTZ-atenolol combination therapy
Number of subjects: 139
Study 8150546 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 139
Study 8150546 — intervention group
Group type: COMPARATOR
Intervention: HCTZ
Number of subjects: 139
Study 3538937 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine and flunitrazepam with N2O/O2 ventilation
Number of subjects: 21
Study 3538937 — intervention group
Group type: COMPARATOR
Intervention: Neuroleptic analgesia (NLA)
Number of subjects: 21
Study 28857388 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin extended-release (XR) 2000 mg once daily
Number of subjects: 539
Study 28857388 — intervention group
Group type: COMPARATOR
Intervention: Metformin immediate-release (IR) 1000 mg twice daily
Number of subjects: 539
Study 27413042 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg/day
Number of subjects: 12527
Study 27413042 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12527
Study 24432923 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/sexually transmitted infection (STI) risk-reduction intervention targeting condom use
Number of subjects: 1181
Study 24432923 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control targeting health issues unrelated to sexual risks
Number of subjects: 1181
Study 22081257 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 46
Study 22081257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 20023577 — intervention group
Group type: EXPERIMENTAL
Intervention: Carmellose 0.5%
Number of subjects: 15
Study 20023577 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronate 0.15%
Number of subjects: 15
Study 17675317 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV
Number of subjects: 8
Study 17675317 — intervention group
Group type: COMPARATOR
Intervention: Air (placebo)
Number of subjects: 8
Study 16819355 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital subtraction angiography (DSA)
Number of subjects: 19
Study 16819355 — intervention group
Group type: EXPERIMENTAL
Intervention: B-mode ultrasonography
Number of subjects: 19
Study 12814444 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine sustained release (1.5 mg o.d.)
Number of subjects: 35
Study 12814444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 10574168 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 135
Study 10574168 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational Therapy (OT)
Number of subjects: 135
Study 10574168 — intervention group
Group type: COMPARATOR
Intervention: Control Therapy (CT)
Number of subjects: 135
Study 8908663 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal electrical stimulation using Conmax and Medicon MS‐105 at frequencies of 10, 20, and 50 Hz
Number of subjects: 9
Study 8908663 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal electrical stimulation using Conmax and Medicon MS‐105
Number of subjects: 9
Study 2058867 — intervention group
Group type: EXPERIMENTAL
Intervention: Low potassium intake (16 mmol/day)
Number of subjects: 12
Study 2058867 — intervention group
Group type: COMPARATOR
Intervention: High potassium intake (96 mmol/day)
Number of subjects: 12
Study 6342837 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (15 mg i.v. + 200 mg/day) for 90 days
Number of subjects: 1395
Study 6342837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1395
Study 6342837 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 1395
Study 31124367 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal perioperative oxygen therapy (≥80% oxygen)
Number of subjects: 282
Study 31124367 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine titration of inspired oxygen
Number of subjects: 282
Study 31124367 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimising oxygen administration
Number of subjects: 282
Study 31124367 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximising oxygen administration
Number of subjects: 282
Study 31124367 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted intraoperative fraction inspired oxygen (FiO2)
Number of subjects: 282
Study 31124367 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to participate in future studies
Number of subjects: 282
Study 28137475 — intervention group
Group type: EXPERIMENTAL
Intervention: Yearlong multicomponent rehabilitation program
Number of subjects: 81
Study 28137475 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 81
Study 25596881 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa treatment initiated after baseline assessment
Number of subjects: 403
Study 25596881 — intervention group
Group type: COMPARATOR
Intervention: Baseline cerebrospinal fluid (CSF) biomarkers
Number of subjects: 403
Study 23980876 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoral plasmid AMEP electrotransfer (1 and 2 mg DNA)
Number of subjects: 5
Study 23980876 — intervention group
Group type: COMPARATOR
Intervention: Control lesions (untreated)
Number of subjects: 5
Study 21378141 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic lower-leg cuff inflation (RCI) at 80 mmHg
Number of subjects: 11
Study 21378141 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic lower-leg cuff inflation (RCI) at 120 mmHg
Number of subjects: 11
Study 21378141 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic lower-leg cuff inflation (RCI) at 40 mmHg
Number of subjects: 11
Study 21378141 — intervention group
Group type: COMPARATOR
Intervention: Sham condition (0 mmHg)
Number of subjects: 11
Study 19411053 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 50) watched 4 weekly episodes of the cooking show, Good Grubbin'
Number of subjects: 101
Study 19411053 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 51) watched 4 weekly episodes on sleep disorders
Number of subjects: 101
Study 17724537 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic guidelines for the treatment of nosocomial pneumonia (group with intervention)
Number of subjects: 0
Study 17724537 — intervention group
Group type: COMPARATOR
Intervention: Historical controls (group without intervention)
Number of subjects: 0
Study 15277150 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous-intensity exercise program (30 min 3 times/wk)
Number of subjects: 60
Study 15277150 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy restriction (4186-6279 kJ/d)
Number of subjects: 60
Study 15277150 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous-intensity exercise program
Number of subjects: 60
Study 15277150 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy restriction
Number of subjects: 60
Study 15277150 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous-intensity exercise and energy restriction
Number of subjects: 60
Study 12040756 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (HBO)
Number of subjects: 7
Study 12040756 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment group (no HBO)
Number of subjects: 7
Study 9808859 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual glyceryl trinitrate (GTN) 800 microg
Number of subjects: 47
Study 9808859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 9808859 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual glyceryl trinitrate (GTN)
Number of subjects: 47
Study 7622990 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor practice (immediate imitation) before the delay
Number of subjects: 192
Study 7622990 — intervention group
Group type: EXPERIMENTAL
Intervention: No motor practice before the delay
Number of subjects: 192
Study 7622990 — intervention group
Group type: COMPARATOR
Intervention: Age-matched control groups
Number of subjects: 192
Study 2539204 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (2.5 mg/kg/day)
Number of subjects: 26
Study 2539204 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine (100 mg/kg/day)
Number of subjects: 26
Study 2539204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 190594 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured preoperative educational program
Number of subjects: 0
Study 190594 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized questionnaires
Number of subjects: 0
Study 6185089 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical arabinosyladenine monophosphate (ara-AMP)
Number of subjects: 55
Study 6185089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 31705750 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Kidney Disease (CKD)
Number of subjects: 9361
Study 31705750 — intervention group
Group type: COMPARATOR
Intervention: No Chronic Kidney Disease (Control)
Number of subjects: 9361
Study 31705750 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Kidney Disease (CKD) with intensive blood pressure reduction
Number of subjects: 9361
Study 31705750 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical cardiovascular disease
Number of subjects: 9361
Study 25559249 — intervention group
Group type: EXPERIMENTAL
Intervention: Core strength training on unstable surfaces (CSTU)
Number of subjects: 39
Study 25559249 — intervention group
Group type: COMPARATOR
Intervention: Core strength training on stable surfaces (CSTS)
Number of subjects: 39
Study 24869931 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab, Trastuzumab, and Docetaxel
Number of subjects: 0
Study 24869931 — intervention group
Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 0
Study 22733899 — intervention group
Group type: EXPERIMENTAL
Intervention: 80-kVp protocol with moderate-concentration CM
Number of subjects: 50
Study 22733899 — intervention group
Group type: COMPARATOR
Intervention: 120-kVp protocol with high-concentration CM
Number of subjects: 50
Study 21203735 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 percent sodium ascorbate gel combined with a surfactant
Number of subjects: 40
Study 21203735 — intervention group
Group type: COMPARATOR
Intervention: 10 percent carbamide peroxide without an antioxidant agent
Number of subjects: 40
Study 17641514 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial breast irradiation (PBI)
Number of subjects: 0
Study 17641514 — intervention group
Group type: COMPARATOR
Intervention: Whole-breast irradiation
Number of subjects: 0
Study 15329918 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (DOX)
Number of subjects: 130
Study 15329918 — intervention group
Group type: COMPARATOR
Intervention: No Doxorubicin (no DOX)
Number of subjects: 130
Study 11060829 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotrafiban
Number of subjects: 0
Study 11060829 — intervention group
Group type: COMPARATOR
Intervention: Aspirin therapy
Number of subjects: 0
Study 9013308 — intervention group
Group type: EXPERIMENTAL
Intervention: Full bladder (group F)
Number of subjects: 796
Study 9013308 — intervention group
Group type: COMPARATOR
Intervention: Empty bladder (group E)
Number of subjects: 796
Study 8357055 — intervention group
Group type: EXPERIMENTAL
Intervention: betaxolol 0.5%
Number of subjects: 76
Study 8357055 — intervention group
Group type: COMPARATOR
Intervention: dipivefrin 0.1%
Number of subjects: 76
Study 3510821 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating a high-carbohydrate meal
Number of subjects: 184
Study 3510821 — intervention group
Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 184
Study 28240687 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy (hemoglobin threshold < 9 g/dL)
Number of subjects: 300
Study 28240687 — intervention group
Group type: COMPARATOR
Intervention: Restrictive transfusion strategy (hemoglobin threshold < 7 g/dL)
Number of subjects: 300
Study 26458258 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 224
Study 26458258 — intervention group
Group type: EXPERIMENTAL
Intervention: Both wine groups
Number of subjects: 224
Study 26458258 — intervention group
Group type: EXPERIMENTAL
Intervention: Both wines
Number of subjects: 224
Study 26458258 — intervention group
Group type: COMPARATOR
Intervention: Mineral water (control)
Number of subjects: 224
Study 23880333 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) group, 8 weeks duration, 1 session per week, 100 minutes per session
Number of subjects: 60
Study 23880333 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 60
Study 23880333 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) group
Number of subjects: 60
Study 23724267 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary sinus antrostomy
Number of subjects: 30
Study 23724267 — intervention group
Group type: COMPARATOR
Intervention: Uncinectomy-only
Number of subjects: 30
Study 23724267 — intervention group
Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 30
Study 18853428 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg once daily
Number of subjects: 80
Study 18853428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 17499084 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered ERP
Number of subjects: 41
Study 17499084 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-administered ERP
Number of subjects: 41
Study 15240647 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavonoids (114 mg/d)
Number of subjects: 56